Study Of An Investigational Drug For Systemic Lupus Erythematosus
Seeking people aged 18 to 70 with systemic lupus erythematosus (SLE) that is being treated with nonbiologic therapies (such as an oral corticosteroid, antimalarial, and/or immunosuppressant) for a study of an investigational monoclonal antibody drug injection.